Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Clinical Genitourinary Cancer
|
May 11, 2024
Association of Elevated C-Reactive Protein with Worsened Outcomes in Different Histologies of Renal Cortical Tumors: Analysis of the INMARC Registry
Cesare Saitta, Jonathan A Afari, Dattatraya Patil, et al.
Clinical Genitourinary Cancer
|
July 7, 2024
Combined Charlson comorbidity/C-Reactive Protein Index Is a Novel Predictor in Renal Cell Carcinoma: Analysis of the International Marker Consortium for Renal Cancer (INMARC) Registry
Julian A Cortes, Cesare Saitta, Kit L Yuen, et al.
Clinical Genitourinary Cancer
|
October 31, 2024
NODESAFE Nomogram: A Novel Score System to Predict Lymph Node Involvement at the Time of Nephrectomy or Nodal Recurrence in Nonmetastatic Renal Cell Carcinoma
Cesare Saitta, Giuseppe Garofano, Jonathan A Afari, et al.
Nature Communications
|
August 15, 2025
Basigin links altered skeletal stem cell lineage dynamics with glucocorticoid-induced bone loss and impaired angiogenesis
Thomas H Ambrosi, David Morales, Kun Chen, et al.
Clinical Genitourinary Cancer
|
August 9, 2023
Outcomes of Consolidative Nephrectomy following Primary Immunotherapy in Advanced Renal Cell Carcinoma: A Multicenter Analysis
Kevin Hakimi, Ava Saidian, Justine Panian, et al.
Urologic Oncology
|
June 26, 2024
Predictive factors for recurrence and outcomes in T1a renal cell carcinoma: Analysis of the INMARC (International Marker Consortium for Renal Cancer) database
Franklin Liu, Luke Wang, Margaret F Meagher, et al.
The Oncologist
|
June 27, 2023
Pathological Outcomes of Patients With Advanced Renal Cell Carcinoma Who Receive Nephrectomy Following Immunotherapy
Justine Panian, Ava Saidian, Kevin Hakimi, et al.
Minerva Urology and Nephrology
|
August 2, 2023
Partial versus radical nephrectomy for complex renal mass: multicenter comparative analysis of functional outcomes (Rosula collaborative group)
Clara Cerrato, Margaret F Meagher, Riccardo Autorino, et al.
Internal Medicine Journal
|
September 5, 2024
6-Thioguanine nucleotide levels are associated with infliximab but not adalimumab levels in inflammatory bowel disease patients on combination therapy
Natalie Yu, Tanya Lee, Daniel Tassone, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Clinical Genitourinary Cancer
|
May 11, 2024
Association of Elevated C-Reactive Protein with Worsened Outcomes in Different Histologies of Renal Cortical Tumors: Analysis of the INMARC Registry
Cesare Saitta, Jonathan A Afari, Dattatraya Patil, et al.
Clinical Genitourinary Cancer
|
July 7, 2024
Combined Charlson comorbidity/C-Reactive Protein Index Is a Novel Predictor in Renal Cell Carcinoma: Analysis of the International Marker Consortium for Renal Cancer (INMARC) Registry
Julian A Cortes, Cesare Saitta, Kit L Yuen, et al.
Clinical Genitourinary Cancer
|
October 31, 2024
NODESAFE Nomogram: A Novel Score System to Predict Lymph Node Involvement at the Time of Nephrectomy or Nodal Recurrence in Nonmetastatic Renal Cell Carcinoma
Cesare Saitta, Giuseppe Garofano, Jonathan A Afari, et al.
Nature Communications
|
August 15, 2025
Basigin links altered skeletal stem cell lineage dynamics with glucocorticoid-induced bone loss and impaired angiogenesis
Thomas H Ambrosi, David Morales, Kun Chen, et al.
Clinical Genitourinary Cancer
|
August 9, 2023
Outcomes of Consolidative Nephrectomy following Primary Immunotherapy in Advanced Renal Cell Carcinoma: A Multicenter Analysis
Kevin Hakimi, Ava Saidian, Justine Panian, et al.
Urologic Oncology
|
June 26, 2024
Predictive factors for recurrence and outcomes in T1a renal cell carcinoma: Analysis of the INMARC (International Marker Consortium for Renal Cancer) database
Franklin Liu, Luke Wang, Margaret F Meagher, et al.
The Oncologist
|
June 27, 2023
Pathological Outcomes of Patients With Advanced Renal Cell Carcinoma Who Receive Nephrectomy Following Immunotherapy
Justine Panian, Ava Saidian, Kevin Hakimi, et al.
Minerva Urology and Nephrology
|
August 2, 2023
Partial versus radical nephrectomy for complex renal mass: multicenter comparative analysis of functional outcomes (Rosula collaborative group)
Clara Cerrato, Margaret F Meagher, Riccardo Autorino, et al.
Internal Medicine Journal
|
September 5, 2024
6-Thioguanine nucleotide levels are associated with infliximab but not adalimumab levels in inflammatory bowel disease patients on combination therapy
Natalie Yu, Tanya Lee, Daniel Tassone, et al.
Page
of 3